A multicenter clinical trial has found that a device known as a bionic pancreas was more effective at maintaining blood glucose levels than standard-of-care management among people with type 1 diabetes.

The 13-week trial tracked 326 participants, ages 6 to 79 years, who had type 1 diabetes and had been using insulin for at least one year.

The UNC Chapel Hill conducted trial was primarily funded by the National Institute of Diabetes and Digestive and Kidney Diseases.

Read full article here.